Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature
  • Search
  • My Account Login
  1. nature
  2. search
advanced

Refine your results by…

Filters ​

Filter By:

Article type ​
Check one or more article types to show results from those article types only.
Journal ​​
Check one or more journals to show results from those journals only.

Choose more journals

Subject Check one or more subjects to show results from those subjects only.
Date ​
Choose a date option to show results from those dates only.

Custom date range

Sort by Relevance ​​
Choose a way to sort results.
Loading Filters

Showing 1–3 of 3 results

Loading Filters
  1. Research | 9 October 2017

    Polypharmacology-based ceritinib repurposing using integrated functional proteomics

    • Uwe.Rix@moffitt.org
    • Brent M Kuenzi
    • , Lily L Remsing Rix
    • , Paul A Stewart
    • , Bin Fang
    • , Fumi Kinose
    • , Annamarie T Bryant
    • , Theresa A Boyle
    • , John M Koomen
    • , Eric B Haura
    •  & Uwe Rix
    Nature Chemical Biology 13 , 1222–1231
    Rights & permissionsfor article Polypharmacology-based ceritinib repurposing using integrated functional proteomics . Opens in a new window.
  2. News & Views | 25 June 2018

    Unraveling the rewired network

    • Uwe.Rix@moffitt.org
    • Vinayak Palve
    • , Brent M. Kuenzi
    •  & Uwe Rix
    Nature Chemical Biology 14 , 746–747
    Rights & permissionsfor article Unraveling the rewired network . Opens in a new window.
  3. Research | 24 January 2019 | Open

    Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia

    • Uwe.Rix@moffitt.org
    • Brent M. Kuenzi
    • , Lily L. Remsing Rix
    • , Fumi Kinose
    • , Jodi L. Kroeger
    • , Jeffrey E. Lancet
    • , Eric Padron
    •  & Uwe Rix
    Scientific Reports 9 , 1–12
    Rights & permissionsfor article Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia . Opens in a new window.

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

nature.com sitemap

Nature portfolio
  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • Nano
  • Protocol Exchange
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Nature Research Academies

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Career development

  • Nature Careers
  • Nature Conferences
  • Nature events

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Italy
  • Nature Japan
  • Nature Korea
  • Nature Middle East

Legal & Privacy

  • Privacy Policy
  • Use of cookies
  • Manage cookies/Do not sell my data
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • California Privacy Statement
Springer Nature

© 2021 Springer Nature Limited

\